Article
Development of Antibody-Fragment–Producing Rice for Neutralization of Human Norovirus
23 Feb 2021
Abstract excerpt
Human norovirus is the leading cause of acute nonbacterial gastroenteritis in people of all ages worldwide. Currently, no licensed norovirus vaccine, pharmaceutical drug, or therapy is available for the control of norovirus infection. Here, we used a rice transgenic system, MucoRice, to produce a variable domain of a llama heavy-chain antibody fragment (VHH) specific for human norovirus (MucoRice-VHH). VHH is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
